These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9414484)

  • 1. Mechanism of inhibition of rat liver bilirubin UDP-glucuronosyltransferase by triphenylalkyl derivatives.
    Said M; Battaglia E; Elass A; Cano V; Ziegler JC; Cartier A; Livertoux MH; Vergoten G; Fournel-Gigleux S; Magdalou J
    J Biochem Mol Toxicol; 1998; 12(1):19-27. PubMed ID: 9414484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitors and substrates of bilirubin: UDP-glucuronosyltransferase. Arylalkylcarboxylic acids.
    Fournel-Gigleux S; Shepherd SR; Carre MC; Burchell B; Siest G; Caubere P
    Eur J Biochem; 1989 Aug; 183(3):653-9. PubMed ID: 2776759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives.
    Said M; Noort D; Magdalou J; Ziegler JC; van der Marel GA; van Boom JH; Mulder GJ; Siest G
    Biochem Biophys Res Commun; 1992 Aug; 187(1):140-5. PubMed ID: 1520294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of bilirubin UDPglucuronosyltransferase activity by triphenylacetic acid and related compounds.
    Fournel S; Grégoire B; Magdalou J; Carre MC; Lafaurie C; Siest G; Caubère P
    Biochim Biophys Acta; 1986 Sep; 883(2):190-6. PubMed ID: 3091075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D; Coughtrie MW; Burchell B; van der Marel GA; van Boom JH; van der Gen A; Mulder GJ
    Eur J Biochem; 1990 Mar; 188(2):309-12. PubMed ID: 2108023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of rat liver microsomal bilirubin UDP-glucuronosyltransferase by ursodeoxycholic acid.
    Sánchez Pozzi EJ; Luquita MG; Catania VA; Rodríguez Garay EA; Mottino AD
    Life Sci; 1994; 55(2):111-20. PubMed ID: 8015354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide.
    D'Andrea V; Pérez LM; Sánchez Pozzi EJ
    Life Sci; 2005 Jun; 77(6):683-92. PubMed ID: 15921999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of UDP-glucuronosyltransferase by 5'-O-amino acid and oligopeptide derivatives of uridine: structure-activity relationships.
    Naydenova ZG; Grancharov KC; Alargov DK; Golovinsky EV; Stanoeva IM; Shalamanova LD; Pajeva IK
    Z Naturforsch C J Biosci; 1998; 53(3-4):173-81. PubMed ID: 9687161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity labeling for evaluation of uridinyl analogs as specific inhibitors of rat liver microsomal UDP-glucuronosyltransferases.
    Radominska A; Paul P; Treat S; Towbin H; Pratt C; Little J; Magdalou J; Lester R; Drake R
    Biochim Biophys Acta; 1994 Apr; 1205(2):336-45. PubMed ID: 8155717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new class of inhibitors of the recombinant human liver UDP-glucuronosyltransferase, UGT1*6.
    Battaglia E; Elass A; Drake RR; Paul P; Treat S; Magdalou J; Fournel-Gigleux S; Siest G; Vergoten G; Lester R
    Biochim Biophys Acta; 1995 Jan; 1243(1):9-14. PubMed ID: 7827113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
    Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
    Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monometoxytrityl derivatives of uridine as inhibitors of a human recombinant UDP-glucuronosyltransferase: UGT1*6.
    Cano V; Lorentz C; Magdalou J; Loppinet V; Siest G; Ziegler JC
    Life Sci; 1997; 61(1):PL1-8. PubMed ID: 9200672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of UDP-glucuronosyltransferases in rat liver microsomes by natural mutagens and carcinogens.
    Grancharov K; Engelberg H; Naydenova Z; Müller G; Rettenmeier AW; Golovinsky E
    Arch Toxicol; 2001 Dec; 75(10):609-12. PubMed ID: 11808922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7.
    Bichlmaier I; Finel M; Sippl W; Yli-Kauhaluoma J
    ChemMedChem; 2007 Dec; 2(12):1730-40. PubMed ID: 17943712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6.
    Ikushiro S; Emi Y; Iyanagi T
    Biochemistry; 2002 Oct; 41(42):12813-20. PubMed ID: 12379124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
    Coffman BL; Green MD; King CD; Tephly TR
    Mol Pharmacol; 1995 Jun; 47(6):1101-5. PubMed ID: 7603447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
    Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
    Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the UDP-glucuronosyltransferases involved in the glucuronidation of an antithrombotic thioxyloside in rat and humans.
    Pless D; Gouze JN; Senay C; Herber R; Leroy P; Barberousse V; Fournel-Gigleux S; Magdalou J
    Drug Metab Dispos; 1999 May; 27(5):588-95. PubMed ID: 10220487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.
    Herber R; Magdalou J; Haumont M; Bidault R; van Es H; Siest G
    Biochim Biophys Acta; 1992 Jun; 1139(1-2):20-4. PubMed ID: 1610916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.